Target Healthcare REIT (LON:THRL) Given “Buy” Rating at Jefferies Financial Group

Target Healthcare REIT (LON:THRL)‘s stock had its “buy” rating reaffirmed by research analysts at Jefferies Financial Group in a report released on Thursday, Digital Look reports. They currently have a GBX 124 price objective on the stock. Jefferies Financial Group’s target price suggests a potential upside of 8.77% from the company’s current price.

Target Healthcare REIT Trading Down 0.5%

LON:THRL opened at GBX 114 on Thursday. The business’s 50-day moving average price is GBX 111.89 and its two-hundred day moving average price is GBX 109.17. Target Healthcare REIT has a 1-year low of GBX 92 and a 1-year high of GBX 117. The firm has a market capitalization of £707.07 million, a price-to-earnings ratio of 8.56, a PEG ratio of 1.48 and a beta of 0.71.

Target Healthcare REIT (LON:THRL) last issued its quarterly earnings data on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share (EPS) for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. Sell-side analysts predict that Target Healthcare REIT will post 6.22 earnings per share for the current year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.